250 related articles for article (PubMed ID: 30939845)
1. Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling.
Takayama KI
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30939845
[TBL] [Abstract][Full Text] [Related]
2. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.
Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y
Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.
Takayama KI; Suzuki T; Fujimura T; Yamada Y; Takahashi S; Homma Y; Suzuki Y; Inoue S
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10461-10466. PubMed ID: 28893982
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
[TBL] [Abstract][Full Text] [Related]
5. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
[TBL] [Abstract][Full Text] [Related]
6. PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells.
Liu W; Wang C; Wang S; Zeng K; Wei S; Sun N; Sun G; Wang M; Zou R; Liu W; Lin L; Song H; Jin Z; Zhao Y
Int J Biol Sci; 2021; 17(1):188-203. PubMed ID: 33390843
[TBL] [Abstract][Full Text] [Related]
7. Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors.
Takayama KI; Fujimura T; Suzuki Y; Inoue S
Commun Biol; 2020 Jul; 3(1):393. PubMed ID: 32704143
[TBL] [Abstract][Full Text] [Related]
8. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells.
Melnyk JE; Steri V; Nguyen HG; Hann B; Feng FY; Shokat KM
Bioorg Med Chem; 2020 Oct; 28(20):115712. PubMed ID: 33069070
[TBL] [Abstract][Full Text] [Related]
9. Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells.
Ferraldeschi R; Welti J; Powers MV; Yuan W; Smyth T; Seed G; Riisnaes R; Hedayat S; Wang H; Crespo M; Nava Rodrigues D; Figueiredo I; Miranda S; Carreira S; Lyons JF; Sharp S; Plymate SR; Attard G; Wallis N; Workman P; de Bono JS
Cancer Res; 2016 May; 76(9):2731-42. PubMed ID: 27197266
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the androgen receptor splicing in prostate cancer cells.
Liu LL; Xie N; Sun S; Plymate S; Mostaghel E; Dong X
Oncogene; 2014 Jun; 33(24):3140-50. PubMed ID: 23851510
[TBL] [Abstract][Full Text] [Related]
11. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
[TBL] [Abstract][Full Text] [Related]
12. The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation.
Nakata D; Nakao S; Nakayama K; Araki S; Nakayama Y; Aparicio S; Hara T; Nakanishi A
Biochem Biophys Res Commun; 2017 Jan; 483(1):271-276. PubMed ID: 28025139
[TBL] [Abstract][Full Text] [Related]
13. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
[TBL] [Abstract][Full Text] [Related]
14. [The mechanisms of prostate cancer progression through androgen receptor].
Goto Y; Sakamoto S; Ichikawa T
Nihon Rinsho; 2016 Jan; 74(1):55-9. PubMed ID: 26793880
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis.
Li H; Wang Z; Tang K; Zhou H; Liu H; Yan L; Guan W; Chen K; Xu H; Ye Z
Eur Urol Focus; 2018 Jul; 4(4):529-539. PubMed ID: 28753843
[TBL] [Abstract][Full Text] [Related]
16. Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer.
Seltzer S; Giannopoulos PN; Bismar TA; Trifiro M; Paliouras M
Asian J Androl; 2023; 25(3):296-308. PubMed ID: 36259569
[TBL] [Abstract][Full Text] [Related]
17. A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities.
Hu R; Isaacs WB; Luo J
Prostate; 2011 Nov; 71(15):1656-67. PubMed ID: 21446008
[TBL] [Abstract][Full Text] [Related]
18. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
[TBL] [Abstract][Full Text] [Related]
19. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
Liu L; Dong X
PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cells.
Nakata D; Koyama R; Nakayama K; Kitazawa S; Watanabe T; Hara T
Prostate; 2017 Jun; 77(9):955-961. PubMed ID: 28397338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]